SUNPHARMA vs WIPRO: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows faster revenue growth and a higher net margin, while WIPRO shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUNPHARMA leads 6; WIPRO leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| Sector | Healthcare | Information Technology |
| Industry | Pharmaceuticals | Computers - Software & Consulting |
Price
| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| Live Price | ₹1,758 | ₹190.41 |
| Day Change | 0.74% | 0.66% |
| Volume | 17.79 L | 4.59 Cr |
| 52-Week High | ₹2,046.9 | ₹273.1 |
| 52-Week Low | ₹1,583.7 | ₹156.79 |
| Distance from 52W High | -14.11% | -30.28% |
Valuation
| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| Market Cap | ₹4.21 L Cr | ₹1.88 L Cr |
| P/E Ratio | 34.79x | 14.69x |
| P/B Ratio | 5.04x | 2.52x |
| EPS | ₹50.46 | ₹13.22 |
| Book Value | ₹348.31 | ₹80.34 |
| Dividend Yield | 0.92% | 4.39% |
Growth
| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.8% | 7.7% |
| EPS Growth (TTM YoY) | 25.6% | -1.6% |
| Qtr Sales Growth | 0% | 1.12% |
| Qtr Profit Growth | 0% | -4.67% |
Profitability & Leverage
| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| ROE | 11.76% | 15.03% |
| ROCE | 9.6% | 14.99% |
| Net Margin | 18.56% | 14.25% |
| Operating Margin | 22.81% | 20.27% |
| Debt to Equity | 0.6x | 0.19x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SUNPHARMA | WIPRO |
|---|---|---|
| Promoter Holding | 52.68%▼ 1.8 pp | 72.58%▼ 0.01 pp |
| FII Holding | 14.36%▼ 0.17 pp | 12.09%▲ 0.95 pp |
| DII Holding | 22.27%▲ 0.09 pp | 5.13%▼ 0.09 pp |
| Public Holding | 10.7%▲ 1.89 pp | 10.08%▼ 0.85 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and WIPRO.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.